Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing

Susanne B Haga; Rachel Mills; Jivan Moaddeb; Nancy Allen LaPointe; Alex Cho; Geoffrey S Ginsburg

doi:10.2217/pgs-2016-0177

Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing

Pharmacogenomics. 2017 Mar;18(4):359-367. doi: 10.2217/pgs-2016-0177. Epub 2017 Feb 22.

Authors

Susanne B Haga¹, Rachel Mills¹, Jivan Moaddeb¹, Nancy Allen LaPointe², Alex Cho³, Geoffrey S Ginsburg¹

Affiliations

¹ Duke Center for Applied Genomics & Precision Medicine, Duke University, Durham, NC, USA.
² Duke Clinical Research Institute, Duke University, Durham, NC, USA.
³ Department of Medicine, Duke University, Durham, NC, USA.

Abstract

Aim: To investigate provider utilization of pharmacist support in the delivery of pharmacogenetic testing in a primary care setting.

Methods: Two primary care clinics within Duke University Health System participated in the study between December 2012 and July 2013. One clinic was provided with an in-house pharmacist and the second clinic had an on-call pharmacist.

Results: Providers in the in-house pharmacist arm consulted with the pharmacist for 13 of 15 cases, or about one of every four patients tested compared with one of every 7.5 patients in the on-call pharmacist arm. A total of 63 tests were ordered, 48 by providers in the pharmacist-in-house arm.

Conclusion: These findings suggest that the availability of an in-house pharmacist increases the likelihood of pharmacogenetic test utilization.

Keywords: delivery model; education; pharmacist consultation; pharmacogenetic testing.

Publication types

Multicenter Study

MeSH terms

Delivery of Health Care / methods*
Female
Follow-Up Studies
Humans
Male
Patient Education as Topic / methods
Pharmacists*
Pharmacogenomic Testing / methods*
Physicians, Primary Care*
Primary Health Care / methods*
Professional Role*
Surveys and Questionnaires

Grants and funding

R01 GM081416/GM/NIGMS NIH HHS/United States